Index | Control (n = 39) | S (n = 91) | D (n = 67) | M ( n = 37) | P |
---|---|---|---|---|---|
Gender | 0.0153 | ||||
F | 19 (48.72%) | 20 (21.98%) | 16 (23.88%) | 8 (21.62%) | |
M | 20 (51.28%) | 71 (78.02%) | 51 (76.12%) | 29 (78.38%) | |
Age | 63.59 ± 9.14 | 62.40 ± 10.56 | 61.67 ± 12.12 | 66.49 ± 10.70 | 0.1591 |
Hypertension | 23 (58.97%) | 53 (58.24%) | 40 (59.70%) | 30 (81.08%) | 0.0670 |
LDL-C | 2.60 ± 0.77 | 2.74 ± 1.07 | 3.10 ± 0.91 | 2.97 ± 1.03 | 0.0449 |
Diabetics | 6 (15.38%) | 27 (29.67%) | 21 (31.34%) | 11 (29.73%) | 0.2608 |
LVEF | - | 59.16 ± 5.17a | 60.60 ± 5.67b | 58.05 ± 8.00 | 0.0644 |
Killip classification | 0.1090 | ||||
Grade I | - | 31 (77.50%)c | 32 (86.49%)d | 15 (68.18%)e | |
Grade II | - | 8 (20.00%)c | 3 (8.11%)d | 2 (9.09%)e | |
Grade III | - | 1 (2.50%)c | 2 (5.41%)d | 4 (18.18%)e | |
Grade IV | - | 0 (0.00%)c | 0 (0.00%)d | 1 (4.55%)e | |
Cys C | 1.30 ± 0.35 | 1.27 ± 0.30 | 1.34 ± 0.44 | 1.51 ± 0.59 | 0.0296 |
Scr | 75.87 ± 19.73 | 73.29 ± 14.82 | 77.87 ± 21.31 | 80.84 ± 29.00 | 0.2370 |
eGFR | 81.44 ± 23.95 | 92.31 ± 31.02 | 90.05 ± 32.50 | 83.56 ± 34.39 | 0.2146 |